WAI GENETICS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board: PJ
Petter Johansen1978
Years since formation: 5 years; since Jun 9, 2020
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 820,000; 1 share class
Total number of shareholders: 22; 5 companies, 17 persons

Financials

Total operating income 2023: 103,180; NOK
Annual total result 2023: 3,762,126; NOK
Total equity 2023: 6,000,000; NOK

Last update: Aug 29, 2024

Management

Board

Name	Role	Shares
PJ Petter Johansen 1978	Chairman	-
DR Davide Rapotez 1980	Board Member	-
KJ Kåre Johan Teigen 1988	Board Member	-

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
PJ Petter Johansen 1978	Ordinary shares	431,250	52.59 %
KJ Kåre Johan Teigen 1988	Ordinary shares	194,990	23.78 %
DR Davide Rapotez 1980	Ordinary shares	51,190	6.24 %
SA Stefanovic Andrija	Ordinary shares	42,500	5.18 %
OJ Odd-Erik Johansen 1974	Ordinary shares	17,900	2.18 %
TH Thyra Hilma Johansen 1952	Ordinary shares	17,400	2.12 %
W WAI GENETICS AS	Ordinary shares	15,336	1.87 %
W WAIAWI ARCTICA AS	Ordinary shares	10,940	1.33 %
O OWNTHAT AS	Ordinary shares	9,430	1.15 %
AA Asmae Armand 1989	Ordinary shares	8,000	0.98 %
T TEIGEN INVEST OG HOLDING AS	Ordinary shares	5,673	0.69 %
W WAI HOLDING OPERATIONS AS	Ordinary shares	4,791	0.58 %
BB Benjamin Bruflot Teigen 2001	Ordinary shares	4,560	0.56 %
UD Utz Daniel 1985	Ordinary shares	2,000	0.24 %
GM Gherlizza Moreno	Ordinary shares	880	0.11 %
SB Stian Bjerkås Henriksen 1995	Ordinary shares	830	0.1 %
DI Daniel Iversen 1982	Ordinary shares	800	0.1 %
CE Caldarelli Emanuele	Ordinary shares	600	0.07 %
KH Kevin-Andre Hansen Svenske 1983	Ordinary shares	330	0.04 %
LB Lara Bez Anibi	Ordinary shares	260	0.03 %
KU Kristofers Userovskis Miks	Ordinary shares	240	0.03 %
AS Antonsen Svein 1954	Ordinary shares	100	< 0.01 %

Shares owned by the WAI GENETICS AS

Name	Share class	Total number of shares	Share
W WAI GENETICS AS	Ordinary shares	15,336	1.87 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	103,180	428,549	241,900
Annual Total Result	3,762,126	25,465	99,570
Total assets	12,556,910	5,536,790	2,825,178
Total liabilities	6,556,911	3,506,738	2,405,178
Total equity	6,000,000	2,030,052	420,000

P&L

Year	2023	2022	2021
Total operating income	103,180	428,549	241,900
Total operating costs	105,747	459,795	142,330
Operating result	-2,567	-31,246	99,570
Financial income/costs	107,387	35,499	0
Profit before tax	104,820	4,253	99,570
Total tax & extraordinary income/cost	-3,657,306	-21,212	0
Annual Total Result	3,762,126	25,465	99,570

Balance overview

Year	2023	2022	2021
Total fixed assets	12,381,073	5,441,333	2,727,163
Total current assets	175,837	95,457	98,015
Total assets	12,556,910	5,536,790	2,825,178
Short term debt	3,983,341	2,685,918	1,584,358
Long term debt	2,573,570	820,820	820,820
Total liabilities	6,556,911	3,506,738	2,405,178
Contributed capital	5,297,015	2,030,052	420,000
Retained earnings	702,985	0	0
Total equity	6,000,000	2,030,052	420,000
Total equity and liabilities	12,556,911	5,536,790	2,825,178

WAI GENETICS AS925 170 291

WAI GENETICS AS

Keywords

Organization

Ownership

Financials

Management

Board

Ownership

Company shareholders

Shares owned by the WAI GENETICS AS

Financials

Summary

P&L

Balance overview

Classification